BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 38519394)

  • 1. Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
    Moore KM; Desai A; Delgado BL; Trabulo SMD; Reader C; Brown NF; Murray ER; Brentnall A; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
    Theranostics; 2020; 10(7):2930-2942. PubMed ID: 32194845
    [No Abstract]   [Full Text] [Related]  

  • 2. The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
    Reader CS; Vallath S; Steele CW; Haider S; Brentnall A; Desai A; Moore KM; Jamieson NB; Chang D; Bailey P; Scarpa A; Lawlor R; Chelala C; Keyse SM; Biankin A; Morton JP; Evans TJ; Barry ST; Sansom OJ; Kocher HM; Marshall JF
    J Pathol; 2019 Nov; 249(3):332-342. PubMed ID: 31259422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
    Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
    Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a
    Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
    Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
    Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
    Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
    Brown NF; Murray ER; Cutmore LC; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
    Pancreatology; 2024 May; 24(3):445-455. PubMed ID: 38519394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling pancreatic cancer in mice for experimental therapeutics.
    Mallya K; Gautam SK; Aithal A; Batra SK; Jain M
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188554. PubMed ID: 33945847
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.